DIFFUSION PHARMACEUTICALS IN - COM PAR

CUSIP: 253748305

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM PAR
Total 13F shares
675,072
Share change
-466,789
Total reported value
$1,248,000
Price per share
$1.85
Number of holders
10
Value change
-$1,352,816
Number of buys
2
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 253748305?
CUSIP 253748305 identifies 253748305 - DIFFUSION PHARMACEUTICALS IN - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DIFFUSION PHARMACEUTICALS IN - COM PAR as of Q3 2019

As of 30 Sep 2019, DIFFUSION PHARMACEUTICALS IN - COM PAR was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 675,072 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Swift Run Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, MORGAN STANLEY, Advisor Group, Inc., and PNC Financial Services Group, Inc.. This page lists 10 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.